Wuhan General Gr Performance
| WUHNDelisted Stock | USD 0.0004 0.00 0.00% |
The firm maintains a market beta of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Wuhan General are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Wuhan General Gr has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical indicators, Wuhan General is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -16.5 M | |
| Discontinued Operations | -713.8 K |
Wuhan |
Wuhan General Relative Risk vs. Return Landscape
If you would invest 0.04 in Wuhan General Gr on September 29, 2024 and sell it today you would earn a total of 0.00 from holding Wuhan General Gr or generate 0.0% return on investment over 90 days. Wuhan General Gr is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Wuhan, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Wuhan General Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Wuhan General's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Wuhan General Gr, and traders can use it to determine the average amount a Wuhan General's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| WUHN |
Based on monthly moving average Wuhan General is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Wuhan General by adding Wuhan General to a well-diversified portfolio.
Wuhan General Fundamentals Growth
Wuhan Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Wuhan General, and Wuhan General fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Wuhan Pink Sheet performance.
| Return On Equity | -0.0878 | ||||
| Return On Asset | -0.005 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 3.05 M | ||||
| Shares Outstanding | 33.93 M | ||||
| Price To Earning | (0.06) X | ||||
| Price To Book | 0.04 X | ||||
| Price To Sales | 0.05 X | ||||
| Revenue | 80.38 M | ||||
| EBITDA | 379.92 K | ||||
| Cash And Equivalents | 18.79 M | ||||
| Cash Per Share | 0.55 X | ||||
| Total Debt | 118.8 M | ||||
| Debt To Equity | 1.11 % | ||||
| Book Value Per Share | 2.34 X | ||||
| Cash Flow From Operations | (21.86 M) | ||||
| Earnings Per Share | (0.35) X | ||||
| Total Asset | 286.58 M | ||||
| Retained Earnings | 15 M | ||||
| Current Asset | 197 M | ||||
| Current Liabilities | 179 M | ||||
About Wuhan General Performance
By examining Wuhan General's fundamental ratios, stakeholders can obtain critical insights into Wuhan General's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Wuhan General is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Wuhan General Group , Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol -based products under the Dr. Wuhan General Group , Inc. is headquartered in Pointe-Claire, Canada. Wuhan General operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 700 people.Things to note about Wuhan General Gr performance evaluation
Checking the ongoing alerts about Wuhan General for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Wuhan General Gr help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Wuhan General Gr is not yet fully synchronised with the market data | |
| Wuhan General Gr has some characteristics of a very speculative penny stock | |
| Wuhan General Gr has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 80.38 M. Net Loss for the year was (10.59 M) with profit before overhead, payroll, taxes, and interest of 14.54 M. | |
| Wuhan General Gr currently holds about 18.79 M in cash with (21.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Wuhan General's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Wuhan General's stock is overvalued or undervalued compared to its peers.
- Examining Wuhan General's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Wuhan General's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Wuhan General's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Wuhan General's pink sheet. These opinions can provide insight into Wuhan General's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Wuhan Pink Sheet
If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges |